Intravenous Immunoglobulin for Patients With Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Apostolos ManolopoulosPanagiotis AndreadisKonstantinos MalandrisIoannis AvgerinosThomas KaragiannisDimitrios KapogiannisMagda TsolakiApostolos TsapasEleni Bekiari

Published in: American journal of Alzheimer's disease and other dementias (2019)

IVIg, albeit safe, is inefficacious for treatment of patients with AD. Future trials targeting earlier stages of disease or applying different dosing regimens may be warranted to clarify its therapeutic potential.

Keyphrases

high dose
current status